Immucell (ICCC) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Immucell (ICCC) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 399.00 |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -491.00 |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 1,157.00 |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -26.00 |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 6,518.00 |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,518.00 |
| Dec 31, 2025 | 529.00 |
| Sep 30, 2025 | 1,112.00 |
| Jun 30, 2025 | 2,550.00 |
| Mar 31, 2025 | 939.00 |
| Dec 31, 2024 | 533.00 |
| Sep 30, 2024 | -1,468.00 |
| Jun 30, 2024 | -3,107.00 |
| Mar 31, 2024 | 473.00 |
| Sep 30, 2023 | -874.00 |
| Jun 30, 2023 | -1,319.00 |
| Mar 31, 2023 | -6,434.00 |
| Dec 31, 2022 | -3,396.00 |
| Sep 30, 2022 | 309.00 |
| Jun 30, 2022 | 489.00 |
| Mar 31, 2022 | 509.00 |
| Dec 31, 2021 | 3,672.00 |
| Sep 30, 2021 | 1,489.00 |
| Jun 30, 2021 | 1,294.00 |
| Mar 31, 2021 | -136.00 |